Home/Filings/4/0001104659-21-121625
4//SEC Filing

Norchi Terrence W 4

Accession 0001104659-21-121625

CIK 0001537561other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 8:06 AM ET

Size

8.3 KB

Accession

0001104659-21-121625

Insider Transaction Report

Form 4
Period: 2021-09-27
Norchi Terrence W
DirectorPres, CEO, Sec, and Treas10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-27+1,000,0001,000,000 total
    Exercise: $0.10Exp: 2031-09-26Common Stock (1,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2021-09-27+1,000,0001,000,000 total
    Exercise: $0.10Exp: 2031-09-26Common Stock (1,000,000 underlying)
Footnotes (2)
  • [F1]The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.
  • [F2]The option was granted pursuant to the Plan. 1/3 of the option vested on the grant date and the remainder of the option shall vest equally on each of the first 24 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.

Issuer

Arch Therapeutics, Inc.

CIK 0001537561

Entity typeother

Related Parties

1
  • filerCIK 0001579935

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 8:06 AM ET
Size
8.3 KB